Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trimipramine maleate (Surmontil maleate) appears to inhibit serotonin transport and norepinephrine uptake by nerve terminals. This increases available norepinephrine or serotonin and prolongs its action. Trimipramine Maleate is the maleate salt form of trimipramine, a tricyclic secondary amine of the dibenzazepine class, with an antidepressant property.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 7,500 | |||
100 mg | 在庫あり | ¥ 11,000 | |||
200 mg | 在庫あり | ¥ 16,000 | |||
500 mg | 在庫あり | ¥ 26,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Trimipramine maleate (Surmontil maleate) appears to inhibit serotonin transport and norepinephrine uptake by nerve terminals. This increases available norepinephrine or serotonin and prolongs its action. Trimipramine Maleate is the maleate salt form of trimipramine, a tricyclic secondary amine of the dibenzazepine class, with an antidepressant property. |
別名 | Surmontil maleate |
分子量 | 410.51 |
分子式 | C24H30N2O4 |
CAS No. | 521-78-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (121.8 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Trimipramine maleate 521-78-8 GPCR/G Protein Immunology/Inflammation Microbiology/Virology Neuroscience Dopamine Receptor 5-HT Receptor Antibacterial Adrenergic Receptor Norepinephrine Histamine Receptor hOCT3 hNAT dopamine 5-HTIA receptors neurological disease serotonin 5-HT1A 5-hydroxytryptamine 5-HT Inhibitor antidepressants 5-hydroxytryptamine Receptor Serotonin Receptor Bacterial Surmontil maleate hOCT1 5-HT1C hDAT Trimipramine inhibit 5-HT2 hSERT noradrenaline Trimipramine Maleate Surmontil Maleate human organic cation transporters anxiolytic DA D2 receptor 5-HTlc receptors hOCT2 inhibitor